Century Therapeutics, Inc. (IPSC)
NASDAQ·Healthcare·Biotechnology
$1.74
+3.27%
Mkt Cap $302.40M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$7.50
Range $2.00 – $19.00
Implied Upside
+332.3%
Consensus $7.50 vs current $1.74
NASDAQ·Healthcare·Biotechnology
$1.74
+3.27%
Mkt Cap $302.40M
No recent rating data.
Price Target (8 analysts)
$7.50
Range $2.00 – $19.00
+332.3%
Consensus $7.50 vs current $1.74